Intelligence Platform

Patents

Browse 140 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6730692

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6623721

Bifunctional chelating compounds containing hydroxamic acid residues

Draximage Limited · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613788

Elevation of circulating blood histamine levels

Maxim Pharmaceuticals, Inc. · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6531120

Ophthalmic histamine compositions and uses thereof

Maxim Pharmaceuticals, Inc. · Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6515003

Heterocyclic derivatives for the treatment of diabetes and other diseases

Maxim Pharmaceuticals, Inc. · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498181

Synergistic tumorcidal response induced by histamine

Maxim Pharmaceuticals, Inc. · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462067

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6407133

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6375946

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. · Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen met

Maxim Pharmaceuticals, Inc. · Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6305380

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen meta

Maxim Pharmaceuticals, Inc. · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6221893

Administration of histamine for therapeutic purposes

Maxim Pharmaceuticals, Inc. · Granted Tue Apr 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6155266

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6080395

Method and composition for topical treatment of damaged tissue using histamine as active i

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 27 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071942

Elevation of circulating blood histamine levels

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071509

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng

Maxim Pharmaceuticals, Inc. · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired